Cleavable linker for peptide synthesis

US11548911B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11548911-B2
Application numberUS-202117170060-A
CountryUS
Kind codeB2
Filing dateFeb 8, 2021
Priority dateAug 9, 2018
Publication dateJan 10, 2023
Grant dateJan 10, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides a new building block for peptide synthesis, which introduces a cleavage site that can be used to generate cleavable fragments subsequent to a peptide sequence.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method comprising: a) synthesizing a peptide on a first solid support, said peptide comprising a first terminal amino group, b) providing a building block comprising the structure: wherein 2≤n≤24, m=2 or 3, A is an acid labile protective group, and B is a tag or base labile protective group; and c) coupling said building block to said first terminal amino group of said peptide. 2. The method of claim 1 , wherein when B is a base labile protective group further comprising: c) removing the base labile protective group B from the building block to provide a deprotected amino group, and d) coupling at least one amino acid building block to the deprotected amino group of the building block, wherein the at least one amino acid building block comprises a second terminal amino group. 3. The method of claim 1 , wherein when B is a base labile protective group further comprising: c) removing the base labile protective group B from the building block to provide a deprotected amino group, e) optionally coupling at least one amino acid building block to the deprotected amino group of the building block, wherein the at least one amino acid building block comprises a second terminal amino group, and e) coupling a tag or a functional group to either (i) the second terminal amino group of the at least one amino acid building block, or (ii) the deprotected amino group of the building block. 4. The method of claim 3 , wherein said tag or functional group is selected from the group consisting of PEG, poly-lysine, poly-arginine, poly-glutamic acid, poly-aspartic acid, biotin, hydrazine, aminooxy, azide, alkynyl, alkenyl, aldehyde, pyrroloalanine, carboxy, and thiol. 5. The method of claim 1 , further comprising: removing the acid labile protective group A from the building block at a pH≤6, thereby also removing other protective groups present on said peptide and cleaving said peptide from the first solid support. 6. The method of claim 5 , further comprising: contacting said cleaved peptide with a buffer having a pH≥8. 7. The method of claim 3 , wherein said tag or functional group is a solubilizing tag, and wherein the method further comprises: g) removing the acid labile protective group A from the building block at a pH≤6, thereby also removing other protective groups present on said peptide and cleaving said peptide from the first solid support, h) purifying said cleaved peptide, and i) cleaving said solubilizing tag at a pH≥8. 8. The method of claim 3 , wherein said tag or functional group is an immobilizing tag, and wherein said method further comprises: g) removing the acid labile protective group A from the building block at a pH≤6, thereby also removing other protective groups present on said peptide and cleaving said peptide from the first solid support, h) immobilizing said cleaved peptide via said immobilizing tag on a second solid support, i) optionally conjugating said cleaved peptide to an additional chemical entity, and j) cleaving said immobilizing tag at a pH≥8. 9. The method of claim 8 , wherein said additional chemical entity is selected from the group consisting of a nucleic acid, an oligonucleotide, and a nucleotide. 10. The method of claim 9 , wherein said nucleotide is a nucleoside-hexaphosphate.

Assignees

Inventors

Classifications

  • C07C271/22Primary

    to carbon atoms of hydrocarbon radicals substituted by carboxyl groups · CPC title

  • C07K1/04Primary

    on carriers {(C07K1/003, C07K1/006 take precedence)} · CPC title

  • by chemical synthesis · CPC title

  • Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11548911B2 cover?
The present invention provides a new building block for peptide synthesis, which introduces a cleavage site that can be used to generate cleavable fragments subsequent to a peptide sequence.
Who is the assignee on this patent?
Roche Sequencing Solutions Inc
What technology area does this patent fall under?
Primary CPC classification C07C271/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).